154 related articles for article (PubMed ID: 34859984)
1. [Metastatic basal cell carcinoma with a SMO gene mutation. A case report].
Zverev NP; Lyakhovets AA; Plaksa IL; Khmelkova DN; Isaev AA
Arkh Patol; 2021; 83(6):35-38. PubMed ID: 34859984
[TBL] [Abstract][Full Text] [Related]
2. Smoothened (SMO) receptor mutations dictate resistance to vismodegib in basal cell carcinoma.
Pricl S; Cortelazzi B; Dal Col V; Marson D; Laurini E; Fermeglia M; Licitra L; Pilotti S; Bossi P; Perrone F
Mol Oncol; 2015 Feb; 9(2):389-97. PubMed ID: 25306392
[TBL] [Abstract][Full Text] [Related]
3. A computational study of hedgehog signalling involved in basal cell carcinoma reveals the potential and limitation of combination therapy.
Buetti-Dinh A; Jensen R; Friedman R
BMC Cancer; 2018 May; 18(1):569. PubMed ID: 29776351
[TBL] [Abstract][Full Text] [Related]
4. Genomic analysis of smoothened inhibitor resistance in basal cell carcinoma.
Sharpe HJ; Pau G; Dijkgraaf GJ; Basset-Seguin N; Modrusan Z; Januario T; Tsui V; Durham AB; Dlugosz AA; Haverty PM; Bourgon R; Tang JY; Sarin KY; Dirix L; Fisher DC; Rudin CM; Sofen H; Migden MR; Yauch RL; de Sauvage FJ
Cancer Cell; 2015 Mar; 27(3):327-41. PubMed ID: 25759019
[TBL] [Abstract][Full Text] [Related]
5. Relation between sonic hedgehog pathway gene polymorphisms and basal cell carcinoma development in the Polish population.
Lesiak A; Sobolewska-Sztychny D; Majak P; Sobjanek M; Wodz K; Sygut KP; Majsterek I; Wozniacka A; Narbutt J
Arch Dermatol Res; 2016 Jan; 308(1):39-47. PubMed ID: 26590974
[TBL] [Abstract][Full Text] [Related]
6. Expression of sonic hedgehog signal transducers, patched and smoothened, in human basal cell carcinoma.
Tojo M; Mori T; Kiyosawa H; Honma Y; Tanno Y; Kanazawa KY; Yokoya S; Kaneko F; Wanaka A
Pathol Int; 1999 Aug; 49(8):687-94. PubMed ID: 10504535
[TBL] [Abstract][Full Text] [Related]
7. Smoothened variants explain the majority of drug resistance in basal cell carcinoma.
Atwood SX; Sarin KY; Whitson RJ; Li JR; Kim G; Rezaee M; Ally MS; Kim J; Yao C; Chang AL; Oro AE; Tang JY
Cancer Cell; 2015 Mar; 27(3):342-53. PubMed ID: 25759020
[TBL] [Abstract][Full Text] [Related]
8. Activating Smoothened mutations in sporadic basal-cell carcinoma.
Xie J; Murone M; Luoh SM; Ryan A; Gu Q; Zhang C; Bonifas JM; Lam CW; Hynes M; Goddard A; Rosenthal A; Epstein EH; de Sauvage FJ
Nature; 1998 Jan; 391(6662):90-2. PubMed ID: 9422511
[TBL] [Abstract][Full Text] [Related]
9. [The role of sonic hedgehog pathway in skin carcinogenesis].
Lesiak A; Sysa-Jedrzejowska A; Narbutt J
Pol Merkur Lekarski; 2010 Aug; 29(170):141-3. PubMed ID: 20842831
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis of drug resistance in smoothened receptor: An in silico study of protein resistivity and specificity.
Sinha N; Chowdhury S; Sarkar RR
Proteins; 2020 Mar; 88(3):514-526. PubMed ID: 31589795
[TBL] [Abstract][Full Text] [Related]
11. Basal cell carcinoma pathogenesis and therapy involving hedgehog signaling and beyond.
Bakshi A; Chaudhary SC; Rana M; Elmets CA; Athar M
Mol Carcinog; 2017 Dec; 56(12):2543-2557. PubMed ID: 28574612
[TBL] [Abstract][Full Text] [Related]
12. Segmental basal cell naevus syndrome caused by an activating mutation in smoothened.
Khamaysi Z; Bochner R; Indelman M; Magal L; Avitan-Hersh E; Sarig O; Sprecher E; Bergman R
Br J Dermatol; 2016 Jul; 175(1):178-81. PubMed ID: 26822128
[TBL] [Abstract][Full Text] [Related]
13. Small Molecule Inhibitors of the Hedgehog Pathway in the Treatment of Basal Cell Carcinoma of the Skin.
Danhof R; Lewis K; Brown M
Am J Clin Dermatol; 2018 Apr; 19(2):195-207. PubMed ID: 28887802
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase A activation inhibits oncogenic Sonic hedgehog signalling and suppresses basal cell carcinoma of the skin.
Makinodan E; Marneros AG
Exp Dermatol; 2012 Nov; 21(11):847-52. PubMed ID: 23163650
[TBL] [Abstract][Full Text] [Related]
15. [Not Available].
Basset-Seguin N
Ann Dermatol Venereol; 2018 Nov; 145 Suppl 5():VS36-VS41. PubMed ID: 30477683
[TBL] [Abstract][Full Text] [Related]
16. Vismodegib resistance in basal cell carcinoma: not a smooth fit.
Ridky TW; Cotsarelis G
Cancer Cell; 2015 Mar; 27(3):315-6. PubMed ID: 25759014
[TBL] [Abstract][Full Text] [Related]
17. The molecular genetics underlying basal cell carcinoma pathogenesis and links to targeted therapeutics.
Iwasaki JK; Srivastava D; Moy RL; Lin HJ; Kouba DJ
J Am Acad Dermatol; 2012 May; 66(5):e167-78. PubMed ID: 20800318
[TBL] [Abstract][Full Text] [Related]
18. Sonic hedgehog pathway dysregulation in skin basal-cell carcinoma of a Polish population.
Lesiak A; Sobolewska-Sztychny D; Danilewicz M; Rogowski-Tylman M; Sysa-Jedrzejowska A; Sobjanek M; Olejniczak-Staruch I; Narbutt J
Folia Histochem Cytobiol; 2013; 51(3):219-24. PubMed ID: 24203628
[TBL] [Abstract][Full Text] [Related]
19. An Investigator-Initiated Open-Label Trial of Sonidegib in Advanced Basal Cell Carcinoma Patients Resistant to Vismodegib.
Danial C; Sarin KY; Oro AE; Chang AL
Clin Cancer Res; 2016 Mar; 22(6):1325-9. PubMed ID: 26546616
[TBL] [Abstract][Full Text] [Related]
20. Hedgehog- and mTOR-targeted therapies for advanced basal cell carcinomas.
Piérard-Franchimont C; Hermanns-Lê T; Paquet P; Herfs M; Delvenne P; Piérard GE
Future Oncol; 2015 Nov; 11(22):2997-3002. PubMed ID: 26437034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
